遺伝的変異,代謝機能障害に関連した脂肪肝疾患,および高齢者の主要な健康結果
PubMedで要約を見る
まとめ
この要約は機械生成です。MBOAT7 の特定の遺伝子変異体 rs641738 C > T は,代謝機能障害に関連した脂肪肝疾患 (MAFLD) の高齢者を心血管疾患から保護する可能性があります. この発見は 高齢者のMAFLD遺伝学について 新たな洞察をもたらします
科学分野
- 遺伝学
- ヘパトロジー
- 心臓病科
- 高齢者医療
背景
- 代謝機能障害関連脂肪肝 (MAFLD) の流行とアウトカムは,中年の集団における遺伝的変異と関連しています.
- MAFLDを患う高齢者の遺伝学的研究は稀であり,この集団における疾患の関連性に関する理解を制限している.
- ASPREE試験は,MAFLDの遺伝子を調査するための健康な高齢者のユニークなコホートを提供します.
研究 の 目的
- 健康な高齢者 (≥70歳) で,既知のMAFLD関連遺伝子変異の臨床的関連性を調査する.
- これらの変異体と発症初期におけるMAFLDの関連性を評価する.
- これらの変異が主要な心血管疾患 (MACE) とすべての原因による死亡率との関連性を追跡調査する.
主な方法
- ASPREEのランダム化試験データを二次的に分析した.
- 8756人の被験者の脂肪肝指数 (FLI) を用いてMAFLDの特定.
- 以前報告された6つのMAFLDに関連した遺伝子変異の評価とMAFLD,MACE,および死亡率との関連.
主要な成果
- GCKRとHSD17B13の変異はMAFLDの流行と関連していたが,PNPLA3,TM6SF2,LYPLAL1,MBOAT7はそうではなかった.
- ほとんどの変種 (PNPLA3,TM6SF2,HSD17B13,GCKR,LYPLAL1) は,全体的なコホートまたはMAFLDサブグループでMACEまたは死亡率との関連を示さなかった.
- MBOAT7 rs641738 C > T変異の同胞性は,共同変数に関係なく,MACEリスクの低下 (aHR 0. 64) と関連していました.
結論
- MBOAT7 rs641738 C > T変種は,MAFLDの高齢者においてMACEに対する保護を提供することができる.
- この保護効果は,他の臨床的リスク要因とは無関係である.
- これらの発見を確認するには,外部コホート検証が必要である.
関連する概念動画
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

